Logo
Aliaxin® LV

Aliaxin® LV

Aliaxin

Medical aesthetic product
  • CE Marked Class III medical device for professional use.
Dermal filler \u2014 hyaluronic acid (lip volume)

Description

Aliaxin® LV Lips Volume is a resorbable, sterile, non-pyrogenic, physiological hyaluronic acid gel filler specifically developed for lip volumisation and contouring, and for correction of medium and deep facial skin sagging. Based on cross-linked, non-animal HA produced by biofermentation, it provides harmonious and natural lip volume, restores firmness and definition, and treats common facial imperfections such as nasolabial folds and perioral wrinkles. The ready-to-use monophasic gel shows high tissue integration and stability, offering long-lasting, natural-looking results.

Bnefits

  • Designed specifically for harmonious increase of lip volume and improved lip contour.
  • Restores lip firmness while maintaining a natural look and feel.
  • Treats medium and deep facial wrinkles and sagging (e.g. nasolabial folds, glabellar and frontal lines).
  • Provides high tissue integration and stability for smooth, natural results and prolonged effect.
  • Ultrapure, non-animal hyaluronic acid produced by patented biofermentation with low BDDE residue and low cross-linking percentage.
  • Monophasic gel, ready to use without additional handling, optimised viscoelastic properties for flow, lift and sculpting.
  • Temporary, fully resorbable filler with typical duration of 6–12 months depending on patient and treatment.

Indications

  • Lip volumisation and contour enhancement.
  • Restoration of physiological facial volumes.
  • Correction of medium and deep sagging skin of the face.
  • Nasolabial folds.
  • Circumoral/perioral wrinkles.
  • Glabellar wrinkles.
  • Frontal (forehead) wrinkles.
  • Facial and acne scars.
  • Areas requiring enrichment of facial tissue (cheeks, chin, cheekbones, lips) with temporary volume increase.

Composition

  • Cross-linked hyaluronic acid (non-animal origin) 25 mg/ml.
  • Natural (non-cross-linked) hyaluronic acid 2.5 mg/ml.
  • Molecular weight fractions: 1000 kDa and 2000 kDa.
  • Phosphate buffer.
  • Water for injectable solutions.
  • Cross-linking agent: BDDE, low percentage cross-linking (<10%) and low BDDE residue (<0.1 ppm).

Formulation

  • Monophasic, sterile, non-pyrogenic, physiological HA gel.
  • Ready-to-use pre-filled syringes; no fragmentation or extra handling required.
  • Rheological profile: Flow 0.53, Lift 39 Pa, Sculpt 0.28.
  • Hydroaction 2/4 and Liftaction 4/5 for combined hydration and lifting performance.

Packaging

  • Total volume: 2 ml (2 × 1 ml pre-filled disposable sterile syringes).
  • 2 sealed blister packs, each containing one single-dose sterile syringe of 1 ml.
  • 4 single-use sterile needles: 27G × 13 mm (½") and 27G × 19 mm (¾").
  • Instruction leaflet (notice).
  • Adhesive labels for patient file and product traceability.

Usage

  • Use exclusively by qualified medical personnel experienced in dermal filler injections.
  • Check integrity of packaging and expiry date; do not use if damaged or expired.
  • Disinfect treatment area and maintain strict aseptic technique.
  • Inject into the skin tissue (mid to deep dermis and/or lip tissue) for extracellular matrix supplementation and intracutaneous volumetric increase.
  • Select injection technique (e.g. linear threading, serial puncture, fanning) according to indication and treatment plan.
  • Adjust injected volume according to degree of correction required and specific treatment area, avoiding overcorrection.
  • After injection, gently massage treated area if needed to ensure even gel distribution.
  • Provide post-treatment advice, including avoiding intense heat/cold, vigorous exercise and manipulation of the lips or treated area for a short period.
  • Single-use device: discard any unused product, syringes and needles as clinical waste.

Contraindications

  • Hypersensitivity to hyaluronic acid or any component of the product.
  • Active skin infection, inflammation or lesions near the intended injection site.
  • Patients with a history of severe allergies or anaphylactic reactions.
  • Pregnancy and breastfeeding (use not recommended).
  • Severe autoimmune or immune system disorders (at physician’s discretion).
  • Individuals under 18 years of age.

Adverse Effects

  • Temporary redness (erythema), swelling, tenderness or pain at the injection site.
  • Bruising or hematoma.
  • Itching or transient discolouration.
  • Palpable nodules or lumps, usually transient.
  • Rare complications such as infection, granuloma formation, vascular occlusion or necrosis if injected intravascularly.
  • Hypersensitivity or allergic reactions in susceptible patients.

Storage Conditions

  • Store at 2–25°C (or 2–28°C as per packaging).
  • Do not freeze.
  • Keep in original packaging and protect from light.
  • Do not use after the expiry date indicated on the pack.

Duration

Typically 6\u201312 months, depending on treated area, degree of correction, patient age, skin type and lifestyle.

Onset

Immediate

Browse more Medical aesthetic product

Top Treatments

Top Cities in the UK